Derivative Liability (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|---|
Jun. 30, 2015 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Dec. 31, 2017 |
|
Derivative Liability (Textual) | |||||
Common stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||
Number of shares issued in private placement | 959,924 | ||||
Price per share | $ 0.01 | ||||
Exercise price of warrant | $ 0.75 | ||||
Placement agent warrants, description | The Company has also issued to the placement agent warrants to purchase our shares of Common Stock equal to 10% of the total shares sold in the offering, or 95,992 shares. | ||||
Gain on derivative liability | $ 9,573 | $ 24,233 | $ 96,998 | ||
Warrants derivative liability fair value | $ 24,233 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Description of placement agent warrants. No definition available.
|
X | ||||||||||
- Definition Warrant derivative liabilities. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|